Free Trial

Colgate-Palmolive (NYSE:CL) Shares Sold by Savoir Faire Capital Management L.P.

Colgate-Palmolive logo with Consumer Staples background

Savoir Faire Capital Management L.P. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 56.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,143 shares of the company's stock after selling 21,086 shares during the quarter. Savoir Faire Capital Management L.P.'s holdings in Colgate-Palmolive were worth $1,676,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $25,000. Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the third quarter worth $53,000. Finally, Gradient Investments LLC lifted its holdings in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after purchasing an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Insider Buying and Selling

In other news, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. The trade was a 16.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by insiders.

Analyst Ratings Changes

CL has been the topic of several recent analyst reports. Piper Sandler assumed coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price on the stock. Jefferies Financial Group lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their target price for the company from $107.00 to $109.00 in a research report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Read Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

CL stock traded down $1.01 during midday trading on Tuesday, hitting $93.61. 4,918,045 shares of the stock traded hands, compared to its average volume of 4,390,670. The stock's fifty day simple moving average is $99.06 and its 200-day simple moving average is $98.55. The firm has a market cap of $76.48 billion, a P/E ratio of 26.82, a PEG ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $75.17 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive's dividend payout ratio is presently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines